•  
  •  
  •  
  •  

2026-05-25 21:32:20

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • IRFC signs Rs 13,527 cr refinancing deal for Hyderabad Metro in major push to urban rail financing
  • Park Medi World Limited to acquire The Medicity Hospital, Rudrapur, Uttarakhand
  • Cyient Semiconductors Announces Strategic Financing with Edelweiss at ~ USD 500 Mn Equity Valuation
  • Puravankara secures 14.57-acre land parcel in Mandur, Bengaluru, with GDV of Rs 2,300 crores
  • Lehar Footwears Delivers Breakout FY26 Performance, Revenue Surges 55%, Profit Soars ~92% YoY

Keywords Selected:  LaurusLabs

Research

  • Q4FY22 Result Update – Laurus Labs - ICICI Direct

Stock Report

  • Laurus Labs Limited recommends 2nd interim dividend of Rs. 1.20
  • Laurus Labs Ltd Q4 FY2025-26 consolidated PAT increases to Rs. 279.14 crores
  • Laurus Labs Ltd reports consolidated net profit of Rs. 251.66 crores in Q3 FY2026
  • Laurus Labs Limited approves interim dividend of Rs. 0.80
  • Laurus Labs Ltd reports rise in Q2FY26 consolidated PAT to Rs. 194.97 crores
  • Laurus Labs Ltd allotted 531.77 acres of land by the Government of Andhra Pradesh
  • Laurus Labs Ltd consolidated Q1 FY2026 PAT at Rs. 163.02 crores
  • Laurus Labs Limited approves 2nd interim dividend of Rs. 0.80
  • Laurus Labs Ltd posts Rs. 232.77 crores consolidated PAT in Q4FY25
  • Laurus Labs Limited receives EIR for API facility Unit-4
  • Laurus Labs Ltd Q3 FY2025 consolidated net profit jumps to Rs. 92.30 crores
  • Laurus Labs Limited invests in Laurus Bio Pvt Ltd
  • Laurus Labs Ltd posts Rs. 19.84 crores consolidated PAT in Q2FY25
  • Laurus Labs Inaugurates New State of the Art R&D Facility at IKP Knowledge Park
  • Laurus Labs concludes successful USFDA audit for API Manufacturing Facility at Hyderabad
  • Laurus Labs Ltd posts consolidated PAT of Rs. 12.51 crores in Q1 FY2025
  • Laurus Labs Limited receives EIR from USFDA for API facilities
  • Laurus Labs Limited recommends 2nd interim dividend of Rs. 0.40
  • Laurus Labs Ltd Q4 FY24 consolidated net profit up QoQ at Rs. 75.61 crores
  • Laurus Labs Limited forms JV company
  • Laurus Labs enters into Joint Venture Agreement with KRKA, Slovenia
  • Laurus Labs Ltd posts Rs. 23.14 crores consolidated PAT in Q3 FY2024
  • Laurus Synthesis Pvt Ltd receives Form 483 with 5 observations from USFDA
  • Laurus Labs Ltd Q2 FY2024 consolidated PAT up QOQ at Rs. 36.95 crores

Latest Post

  • IRFC signs Rs 13,527 cr refinancing deal for Hyderabad Metro in major push to urban rail financing
  • Park Medi World Limited to acquire The Medicity Hospital, Rudrapur, Uttarakhand
  • Cyient Semiconductors Announces Strategic Financing with Edelweiss at ~ USD 500 Mn Equity Valuation
  • Puravankara secures 14.57-acre land parcel in Mandur, Bengaluru, with GDV of Rs 2,300 crores
  • Lehar Footwears Delivers Breakout FY26 Performance, Revenue Surges 55%, Profit Soars ~92% YoY


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025